{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:11:24Z","timestamp":1793067084171,"version":"4.5.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21NS129021-01A1"],"award-info":[{"award-number":["R21NS129021-01A1"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009382","name":"Solve ME\/CFS Initiative","doi-asserted-by":"publisher","award":["Catalyst Awards 2025"],"award-info":[{"award-number":["Catalyst Awards 2025"]}],"id":[{"id":"10.13039\/100009382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08575-3","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:34:44Z","timestamp":1783701284000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of rapamycin treatment with the modulation of purine metabolism, reduced microglial inflammatory responses, improved mitochondrial energy metabolism, and alleviation of fatigue symptoms in ME\/CFS subjects: pilot findings from phase-II observational study"],"prefix":"10.1186","volume":"24","author":[{"given":"Brooke","family":"Gile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarojini","family":"Bulbule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubaraq A.","family":"Toriola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabnam","family":"Marium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Benko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Grach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucinda","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brayden","family":"Yellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Berner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bela","family":"Chheda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Gottschalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0523-8504","authenticated-orcid":false,"given":"Avik","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"8575_CR1","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fped.2019.00131","volume":"7","author":"KJ Friedman","year":"2019","unstructured":"Friedman KJ. Advances in ME\/CFS: Past, Present, and Future. Front Pediatr. 2019;7:131.","journal-title":"Front Pediatr"},{"key":"8575_CR2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nrn3087","volume":"12","author":"ST Holgate","year":"2011","unstructured":"Holgate ST, Komaroff AL, Mangan D, Wessely S. Chronic fatigue syndrome: understanding a complex illness. Nat Rev Neurosci. 2011;12:539\u201344.","journal-title":"Nat Rev Neurosci"},{"key":"8575_CR3","doi-asserted-by":"publisher","first-page":"102259","DOI":"10.1016\/j.xcrm.2025.102259","volume":"6","author":"AL Komaroff","year":"2025","unstructured":"Komaroff AL, Dantzer R. Causes of symptoms and symptom persistence in long COVID and myalgic encephalomyelitis\/chronic fatigue syndrome. Cell Rep Med. 2025;6:102259.","journal-title":"Cell Rep Med"},{"key":"8575_CR4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1365-2796.2011.02428.x","volume":"270","author":"BM Carruthers","year":"2011","unstructured":"Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, Staines D, Powles AC, Speight N, Vallings R, et al. Myalgic encephalomyelitis: International Consensus Criteria. J Intern Med. 2011;270:327\u201338.","journal-title":"J Intern Med"},{"key":"8575_CR5","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12967-018-1644-y","volume":"16","author":"S Rasa","year":"2018","unstructured":"Rasa S, Nora-Krukle Z, Henning N, Eliassen E, Shikova E, Harrer T, Scheibenbogen C, Murovska M, Prusty BK. European Network on MC: Chronic viral infections in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS). J Transl Med. 2018;16:268.","journal-title":"J Transl Med"},{"key":"8575_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13027-023-00485-z","volume":"18","author":"CG Gottschalk","year":"2023","unstructured":"Gottschalk CG, Peterson D, Armstrong J, Knox K, Roy A. Potential molecular mechanisms of chronic fatigue in long haul COVID and other viral diseases. Infect Agent Cancer. 2023;18:7.","journal-title":"Infect Agent Cancer"},{"key":"8575_CR7","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.autrev.2019.05.006","volume":"18","author":"RK Gherardi","year":"2019","unstructured":"Gherardi RK, Crepeaux G, Authier FJ. Myalgia and chronic fatigue syndrome following immunization: macrophagic myofasciitis and animal studies support linkage to aluminum adjuvant persistency and diffusion in the immune system. Autoimmun Rev. 2019;18:691\u2013705.","journal-title":"Autoimmun Rev"},{"key":"8575_CR8","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12967-021-02833-2","volume":"19","author":"KJ Wirth","year":"2021","unstructured":"Wirth KJ, Scheibenbogen C. Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS). J Transl Med. 2021;19:162.","journal-title":"J Transl Med"},{"key":"8575_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12026-024-09557-7","volume":"73","author":"ME Drosen","year":"2025","unstructured":"Drosen ME, Bulbule S, Gottschalk G, Peterson D, Allen LA, Arnold LA, Roy A. Inactivation of ATG13 stimulates chronic demyelinating pathologies in muscle-serving nerves and spinal cord. Immunol Res. 2025;73:27.","journal-title":"Immunol Res"},{"key":"8575_CR10","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1186\/s12967-023-04678-3","volume":"21","author":"N Azcue","year":"2023","unstructured":"Azcue N, Del Pino R, Acera M, Fernandez-Valle T, Ayo-Mentxakatorre N, Perez-Concha T, Murueta-Goyena A, Lafuente JV, Prada A, de Lopez A, et al. Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome. J Transl Med. 2023;21:814.","journal-title":"J Transl Med"},{"key":"8575_CR11","doi-asserted-by":"publisher","first-page":"e036752","DOI":"10.1161\/JAHA.124.036752","volume":"14","author":"MS Khan","year":"2025","unstructured":"Khan MS, Miller AJ, Ejaz A, Molinger J, Goyal P, MacLeod DB, Swavely A, Wilson E, Pergola M, Tandri H, et al. Cerebral Blood Flow in Orthostatic Intolerance. J Am Heart Assoc. 2025;14:e036752.","journal-title":"J Am Heart Assoc"},{"key":"8575_CR12","doi-asserted-by":"publisher","first-page":"20210033","DOI":"10.1515\/em-2021-0033","volume":"11","author":"CL Gaglio","year":"2022","unstructured":"Gaglio CL, Islam MF, Cotler J, Jason LA. Orthostatic intolerance and neurocognitive impairment in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS). Epidemiol Methods. 2022;11:20210033.","journal-title":"Epidemiol Methods"},{"key":"8575_CR13","first-page":"43","volume":"173","author":"AL Komaroff","year":"1993","unstructured":"Komaroff AL. Clinical presentation of chronic fatigue syndrome. Ciba Found Symp. 1993;173:43\u201354. discussion 54\u201361.","journal-title":"Ciba Found Symp"},{"key":"8575_CR14","doi-asserted-by":"crossref","unstructured":"Paul BD, Lemle MD, Komaroff AL, Snyder SH. Redox imbalance links COVID-19 and myalgic encephalomyelitis\/chronic fatigue syndrome. Proc Natl Acad Sci U S A. 2021;118","DOI":"10.1073\/pnas.2024358118"},{"key":"8575_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41419-025-08162-2","volume":"17","author":"M Nunes","year":"2026","unstructured":"Nunes M, Kell L, Slaghekke A, Wust RC, Fielding BC, Kell DB, Pretorius E. Virus-induced endothelial senescence as a cause and driving factor for ME\/CFS and long COVID: mediated by a dysfunctional immune system. Cell Death Dis. 2026;17:16.","journal-title":"Cell Death Dis"},{"key":"8575_CR16","doi-asserted-by":"publisher","first-page":"e2426564122","DOI":"10.1073\/pnas.2426564122","volume":"122","author":"V Shankar","year":"2025","unstructured":"Shankar V, Wilhelmy J, Curtis EJ, Michael B, Cervantes L, Mallajosyula V, Davis RW, Snyder M, Younis S, Robinson WH, et al. Oxidative stress is a shared characteristic of ME\/CFS and Long COVID. Proc Natl Acad Sci U S A. 2025;122:e2426564122.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8575_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s00011-025-02158-6","volume":"75","author":"MA Toriola","year":"2026","unstructured":"Toriola MA, Timlin E, Bulbule S, Reyes A, Adedeji OM, Gottschalk CG, Barua A, Arnold LA, Roy A. Genetic depletion of the early autophagy protein ATG13 impairs mitochondrial energy metabolism, augments oxidative stress, induces the polarization of macrophages to the M1 inflammatory mode, and compromises myelin integrity in skeletal muscle. Inflamm Res. 2026;75:26.","journal-title":"Inflamm Res"},{"key":"8575_CR18","doi-asserted-by":"publisher","first-page":"945","DOI":"10.2967\/jnumed.113.131045","volume":"55","author":"Y Nakatomi","year":"2014","unstructured":"Nakatomi Y, Mizuno K, Ishii A, Wada Y, Tanaka M, Tazawa S, Onoe K, Fukuda S, Kawabe J, Takahashi K, et al. Neuroinflammation in Patients with Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis: An (1)(1)C\u00aePK11195 PET Study. J Nucl Med. 2014;55:945\u201350.","journal-title":"J Nucl Med"},{"key":"8575_CR19","doi-asserted-by":"publisher","first-page":"103484","DOI":"10.1016\/j.autrev.2023.103484","volume":"23","author":"J-S Lee","year":"2024","unstructured":"Lee J-S, Sato W, Son C-G. Brain-regional characteristics and neuroinflammation in ME\/CFS patients from neuroimaging: A systematic review and meta-analysis. Autoimmun rev. 2024;23:103484.","journal-title":"Autoimmun rev"},{"key":"8575_CR20","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1186\/s12967-023-04587-5","volume":"21","author":"NEM Sanal-Hayes","year":"2023","unstructured":"Sanal-Hayes NEM, McLaughlin M, Hayes LD, Mair JL, Ormerod J, Carless D, Hilliard N, Meach R, Ingram J, Sculthorpe NF. A scoping review of \u2018Pacing\u2019 for management of Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS): lessons learned for the long COVID pandemic. J Transl Med. 2023;21:720.","journal-title":"J Transl Med"},{"key":"8575_CR21","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1186\/s12967-025-07213-8","volume":"23","author":"BT Ruan","year":"2025","unstructured":"Ruan BT, Bulbule S, Gile B, Reyes A, Chheda B, Bateman L, Bell J, Yellman B, Grach SL, Berner J, et al. Low-dose rapamycin alleviates clinical symptoms of fatigue and PEM in ME\/CFS patients via improvement of autophagy: a pilot study. J Transl Med. 2025;23:1148.","journal-title":"J Transl Med"},{"key":"8575_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev.bi.25.070156.001011","volume":"25","author":"CE Carter","year":"1956","unstructured":"Carter CE. Metabolism of purines and pyrimidines. Annu Rev Biochem. 1956;25:123\u201346.","journal-title":"Annu Rev Biochem"},{"key":"8575_CR23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0021-9258(19)57126-5","volume":"202","author":"JM Buchanan","year":"1953","unstructured":"Buchanan JM, Schulman MP. Biosynthesis of the purines. III. Reactions of formate and inosinic acid and an effect of the citrovorum factor. J Biol Chem. 1953;202:241\u201352.","journal-title":"J Biol Chem"},{"key":"8575_CR24","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1126\/science.109.2833.377","volume":"109","author":"WE Cohn","year":"1949","unstructured":"Cohn WE. The Separation of Purine and Pyrimidine Bases and of Nucleotides by Ion Exchange. Science. 1949;109:377\u20138.","journal-title":"Science"},{"key":"8575_CR25","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1600-0773.1956.tb01389.x","volume":"12","author":"S Jorgensen","year":"1956","unstructured":"Jorgensen S. Breakdown of adenine and hypoxanthine nucleotides and nucleosides in human plasma. Acta Pharmacol Toxicol (Copenh). 1956;12:294\u2013302.","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"key":"8575_CR26","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1038\/1811594a0","volume":"181","author":"K Burton","year":"1958","unstructured":"Burton K. Energy of adenosine triphosphate. Nature. 1958;181:1594\u20135.","journal-title":"Nature"},{"key":"8575_CR27","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1073\/pnas.70.3.787","volume":"70","author":"S Mizuno","year":"1973","unstructured":"Mizuno S, Rabinovitz M. Factor-promoted dissociation of free ribosomes in a rabbit reticulocyte lysate system: inhibition and requirement for an energy source. Proc Natl Acad Sci U S A. 1973;70:787\u201391.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8575_CR28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1146\/annurev-immunol-051116-052406","volume":"37","author":"J Linden","year":"2019","unstructured":"Linden J, Koch-Nolte F, Dahl G. Purine Release, Metabolism, and Signaling in the Inflammatory Response. Annu Rev Immunol. 2019;37:325\u201347.","journal-title":"Annu Rev Immunol"},{"key":"8575_CR29","doi-asserted-by":"publisher","first-page":"E827","DOI":"10.1152\/ajpendo.00378.2020","volume":"319","author":"M Furuhashi","year":"2020","unstructured":"Furuhashi M. New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity. Am J Physiol Endocrinol Metab. 2020;319:E827\u201334.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"8575_CR30","doi-asserted-by":"publisher","first-page":"6436","DOI":"10.4049\/jimmunol.168.12.6436","volume":"168","author":"JM Labasi","year":"2002","unstructured":"Labasi JM, Petrushova N, Donovan C, McCurdy S, Lira P, Payette MM, Brissette W, Wicks JR, Audoly L, Gabel CA. Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J Immunol. 2002;168:6436\u201345.","journal-title":"J Immunol"},{"key":"8575_CR31","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/sj.bjp.0702333","volume":"126","author":"R Brambilla","year":"1999","unstructured":"Brambilla R, Burnstock G, Bonazzi A, Ceruti S, Cattabeni F, Abbracchio MP. Cyclo-oxygenase-2 mediates P2Y receptor-induced reactive astrogliosis. Br J Pharmacol. 1999;126:563\u20137.","journal-title":"Br J Pharmacol"},{"key":"8575_CR32","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00418-006-0180-7","volume":"126","author":"Z Xiang","year":"2006","unstructured":"Xiang Z, Lv J, Jiang P, Chen C, Jiang B, Burnstock G. Expression of P2X receptors on immune cells in the rat liver during postnatal development. Histochem Cell Biol. 2006;126:453\u201363.","journal-title":"Histochem Cell Biol"},{"key":"8575_CR33","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/978-94-007-1217-1_7","volume":"55","author":"M Koeppen","year":"2011","unstructured":"Koeppen M, Di Virgilio F, Clambey ET, Eltzschig HK. Purinergic regulation of airway inflammation. Subcell Biochem. 2011;55:159\u201393.","journal-title":"Subcell Biochem"},{"key":"8575_CR34","doi-asserted-by":"crossref","unstructured":"McGregor NR, Armstrong CW, Lewis DP, Gooley PR. Post-exertional malaise is associated with hypermetabolism, hypoacetylation and purine metabolism deregulation in ME\/CFS cases. Diagnostics (Basel). 2019;9","DOI":"10.3390\/diagnostics9030070"},{"key":"8575_CR35","doi-asserted-by":"publisher","first-page":"117957352412716","DOI":"10.1177\/11795735241271675","volume":"16","author":"S Bulbule","year":"2024","unstructured":"Bulbule S, Gottschalk CG, Drosen ME, Peterson D, Arnold LA, Roy A. Dysregulation of tetrahydrobiopterin metabolism in myalgic encephalomyelitis\/chronic fatigue syndrome by pentose phosphate pathway. J Cent Nerv Syst Dis. 2024;16:11795735241271675.","journal-title":"J Cent Nerv Syst Dis"},{"key":"8575_CR36","doi-asserted-by":"publisher","first-page":"5292","DOI":"10.1016\/S0021-9258(19)34120-1","volume":"265","author":"Y Natsumeda","year":"1990","unstructured":"Natsumeda Y, Ohno S, Kawasaki H, Konno Y, Weber G, Suzuki K. Two distinct cDNAs for human IMP dehydrogenase. J Biol Chem. 1990;265:5292\u20135.","journal-title":"J Biol Chem"},{"key":"8575_CR37","doi-asserted-by":"publisher","first-page":"7347","DOI":"10.1074\/jbc.270.13.7347","volume":"270","author":"J Nakamura","year":"1995","unstructured":"Nakamura J, Lou L. Biochemical characterization of human GMP synthetase. J Biol Chem. 1995;270:7347\u201353.","journal-title":"J Biol Chem"},{"key":"8575_CR38","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1021\/acschemneuro.4c00444","volume":"15","author":"S Abujrais","year":"2024","unstructured":"Abujrais S, Vallianatou T, Bergquist J. Untargeted Metabolomics and Quantitative Analysis of Tryptophan Metabolites in Myalgic Encephalomyelitis Patients and Healthy Volunteers: A Comparative Study Using High-Resolution Mass Spectrometry. ACS Chem Neurosci. 2024;15:3525\u201334.","journal-title":"ACS Chem Neurosci"},{"key":"8575_CR39","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.bbrc.2016.11.119","volume":"482","author":"YJ Kim","year":"2017","unstructured":"Kim YJ, Ryu HM, Choi JY, Cho JH, Kim CD, Park SH, Kim YL. Hypoxanthine causes endothelial dysfunction through oxidative stress-induced apoptosis. Biochem Biophys Res Commun. 2017;482:821\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"8575_CR40","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1365-2133.2011.10476.x","volume":"165","author":"MM Mutizwa","year":"2011","unstructured":"Mutizwa MM, Berk DR, Anadkat MJ. Treatment of facial angiofibromas with topical application of oral rapamycin solution (1mgmL(-1)) in two patients with tuberous sclerosis. Br J Dermatol. 2011;165:922\u20133.","journal-title":"Br J Dermatol"},{"key":"8575_CR41","doi-asserted-by":"publisher","first-page":"5681","DOI":"10.1007\/s11357-025-01532-w","volume":"47","author":"G Harinath","year":"2025","unstructured":"Harinath G, Lee V, Nyquist A, Moel M, Wouters M, Hagemeier J, Verkennes B, Tacubao C, Nasher S, Kauppi K, et al. The bioavailability and blood levels of low-dose rapamycin for longevity in real-world cohorts of normative aging individuals. Geroscience. 2025;47:5681\u201394.","journal-title":"Geroscience"},{"key":"8575_CR42","doi-asserted-by":"crossref","unstructured":"Jason LA, Evans M, Brown M, Porter N, Brown A, Hunnell J, Anderson V, Lerch A. Fatigue scales and chronic fatigue syndrome: issues of sensitivity and specificity. Disabil Stud Q. 2011;31","DOI":"10.18061\/dsq.v31i1.1375"},{"key":"8575_CR43","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.bbi.2012.01.014","volume":"26","author":"LA Jason","year":"2012","unstructured":"Jason LA, Unger ER, Dimitrakoff JD, Fagin AP, Houghton M, Cook DB, Marshall GD Jr., Klimas N, Snell C. Minimum data elements for research reports on CFS. Brain Behav Immun. 2012;26:401\u20136.","journal-title":"Brain Behav Immun"},{"key":"8575_CR44","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1089\/bsp.2011.0042","volume":"9","author":"AA Adalja","year":"2011","unstructured":"Adalja AA, Watson M, Wollner S, Toner E. A possible approach to large-scale laboratory testing for acute radiation sickness after a nuclear detonation. Biosecur Bioterror. 2011;9:345\u201350.","journal-title":"Biosecur Bioterror"},{"key":"8575_CR45","doi-asserted-by":"crossref","unstructured":"Rahman AFMT, Benko A, Bulbule S, Gottschalk CG, Arnold LA, Roy A. Tetrahydrobiopterin in myalgic encephalomyelitis\/chronic fatigue syndrome: a friend or foe? Biomolecules. 2025;15(1):102.","DOI":"10.3390\/biom15010102"},{"key":"8575_CR46","first-page":"908","volume":"17","author":"M Moel","year":"2025","unstructured":"Moel M, Harinath G, Lee V, Nyquist A, Morgan SL, Isman A, Zalzala S. Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results. Aging. 2025;17:908\u201336.","journal-title":"Aging"},{"key":"8575_CR47","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/01.ftd.0000245680.38143.ca","volume":"28","author":"NT Vethe","year":"2006","unstructured":"Vethe NT, Bergan S. Determination of inosine monophosphate dehydrogenase activity in human CD4\u2009+\u2009cells isolated from whole blood during mycophenolic acid therapy. Ther Drug Monit. 2006;28:608\u201313.","journal-title":"Ther Drug Monit"},{"key":"8575_CR48","doi-asserted-by":"publisher","first-page":"15754","DOI":"10.1021\/acs.analchem.4c03719","volume":"96","author":"GA Nagana Gowda","year":"2024","unstructured":"Nagana Gowda GA, Pascua V, Hill L, Djukovic D, Wang D, Raftery D. Discovery of Hypoxanthine and Inosine as Robust Biomarkers for Predicting the Preanalytical Quality of Human Plasma and Serum for Metabolomics. Anal Chem. 2024;96:15754\u201364.","journal-title":"Anal Chem"},{"key":"8575_CR49","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1182\/blood.V128.22.1640.1640","volume":"128","author":"G Garcia-Manero","year":"2016","unstructured":"Garcia-Manero G, Yang H, Fang Z, Kantarjian HM, DiNardo CD, Jabbour EJ, Pemmaraju N, Daver N, Delumpa R, Loiselle C. Phase 1 Results of FF-10501-01, a Novel Inosine 5\u2019-Monophosphate Dehydrogenase Inhibitor, in Advanced Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS), Including Hypomethylating Agent (HMA) Failures. Blood. 2016;128:1640.","journal-title":"Blood"},{"key":"8575_CR50","doi-asserted-by":"publisher","first-page":"120849","DOI":"10.1016\/j.cca.2026.120849","volume":"584","author":"X Qian","year":"2026","unstructured":"Qian X, Deng Y, Guo T, Huang X, Yan C, Gao X, Wu Y, Hu S, Tan J, Chong L, et al. Plasma non-targeted metabolomics unveils the metabolic signatures of trans-right ventricle in pulmonary arterial hypertension associated with atrial septal defect. Clin Chim Acta. 2026;584:120849.","journal-title":"Clin Chim Acta"},{"key":"8575_CR51","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0022-2828(92)93154-C","volume":"24","author":"E Zoref-Shani","year":"1992","unstructured":"Zoref-Shani E, Bromberg Y, Shirin C, Sidi Y, Sperling O. Metabolic fate of hypoxanthine and inosine in cultured cardiomyocytes. J Mol Cell Cardiol. 1992;24:183\u20139.","journal-title":"J Mol Cell Cardiol"},{"key":"8575_CR52","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/cbf.3029","volume":"32","author":"AF Rodrigues","year":"2014","unstructured":"Rodrigues AF, Roecker R, Junges GM, de Lima DD, da Cruz JG, Wyse AT, Dal Magro DD. Hypoxanthine induces oxidative stress in kidney of rats: protective effect of vitamins E plus C and allopurinol. Cell Biochem Funct. 2014;32:387\u201394.","journal-title":"Cell Biochem Funct"},{"key":"8575_CR53","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1373\/clinchem.2006.081968","volume":"53","author":"S Bremer","year":"2007","unstructured":"Bremer S, Rootwelt H, Bergan S. Real-time PCR determination of IMPDH1 and IMPDH2 expression in blood cells. Clin Chem. 2007;53:1023\u20139.","journal-title":"Clin Chem"},{"key":"8575_CR54","doi-asserted-by":"crossref","unstructured":"Ren Y, Wu T, Liu Z, Li L, Li Y, Xin G, Peng S, Niu J, Chen B, Cai H. IMPDH2 facilitates CD4+ T cell activation through AKT\/mTOR pathway by upregulating SRPK1 in myasthenia gravis. Clin Immunol. 2025;in press:110634.","DOI":"10.1016\/j.clim.2025.110634"},{"key":"8575_CR55","doi-asserted-by":"publisher","first-page":"115116","DOI":"10.1016\/j.celrep.2024.115116","volume":"44","author":"B Zhou","year":"2025","unstructured":"Zhou B, Zhao Q, Hou G, He J, Sha N, Zheng K, Peng H, Wang W, Zhou Y, Chen T, Jiang Y. IMPDH2 dephosphorylation under FGFR signaling promotes S-phase progression and tumor growth. Cell Rep. 2025;44:115116.","journal-title":"Cell Rep"},{"key":"8575_CR56","doi-asserted-by":"crossref","unstructured":"Plana-Bonamais\u00f3 A, L\u00f3pez-Begines S, Fern\u00e1ndez-Justel D, Junza A, Soler-Tapia A, Andilla J, Loza-Alvarez P, Rosa JL, Miralles E, Casals I, et al. Post-translational regulation of retinal IMPDH1 in vivo to adjust GTP synthesis to illumination conditions. eLife. 2020;9.","DOI":"10.7554\/eLife.56418"},{"key":"8575_CR57","doi-asserted-by":"publisher","first-page":"227","DOI":"10.7326\/0003-4819-92-2-227","volume":"92","author":"KREISBERG RA","year":"1980","unstructured":"KREISBERG RA. Lactate homeostasis and lactic acidosis. Ann Intern Med. 1980;92:227\u201337.","journal-title":"Ann Intern Med"},{"key":"8575_CR58","doi-asserted-by":"publisher","first-page":"102337","DOI":"10.1016\/j.redox.2022.102337","volume":"53","author":"R Bakalova","year":"2022","unstructured":"Bakalova R, Aoki I, Zhelev Z, Higashi T. Cellular redox imbalance on the crossroad between mitochondrial dysfunction, senescence, and proliferation. Redox Biol. 2022;53:102337.","journal-title":"Redox Biol"},{"key":"8575_CR59","doi-asserted-by":"publisher","first-page":"9813486","DOI":"10.1155\/2022\/9813486","volume":"2022","author":"Z Li","year":"2022","unstructured":"Li Z, Xu D, Li X, Deng Y, Li C. Redox imbalance in chronic inflammatory diseases. Biomed Res Int. 2022;2022:9813486.","journal-title":"Biomed Res Int"},{"key":"8575_CR60","doi-asserted-by":"publisher","first-page":"111975","DOI":"10.1016\/j.bbr.2019.111975","volume":"372","author":"AJM Chaves-Filho","year":"2019","unstructured":"Chaves-Filho AJM, Macedo DS, de Lucena DF, Maes M. Shared microglial mechanisms underpinning depression and chronic fatigue syndrome and their comorbidities. Behav Brain Res. 2019;372:111975.","journal-title":"Behav Brain Res"},{"key":"8575_CR61","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1097\/j.pain.0000000000002927","volume":"164","author":"C Mueller","year":"2023","unstructured":"Mueller C, Fang YD, Jones C, McConathy JE, Raman F, Lapi SE, Younger JW. Evidence of neuroinflammation in fibromyalgia syndrome: a [ 18 F]DPA-714 positron emission tomography study. Pain. 2023;164:2285\u201395.","journal-title":"Pain"},{"key":"8575_CR62","doi-asserted-by":"publisher","first-page":"e643","DOI":"10.1002\/iid3.643","volume":"10","author":"X Yao","year":"2022","unstructured":"Yao X, Jin G, Liu D, Zhang X, Yang Y, Chen Y, Duan Z, Bi Y, Yan F, Yang Y. Inducible nitric oxide synthase regulates macrophage polarization via the MAPK signals in concanavalin A-induced hepatitis. Immun Inflamm Dis. 2022;10:e643.","journal-title":"Immun Inflamm Dis"},{"key":"8575_CR63","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s11302-024-09997-8","volume":"21","author":"H Wang","year":"2025","unstructured":"Wang H, Wei Y, Wang N. Purinergic pathways and their clinical use in the treatment of acute myeloid leukemia. Purinergic Signal. 2025;21:735\u201346.","journal-title":"Purinergic Signal"},{"key":"8575_CR64","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s11302-025-10083-w","volume":"21","author":"A Collado","year":"2025","unstructured":"Collado A, Zhou Z. Macrophage P2Y(6) receptor signalling as a key mediator and therapeutic target in atherosclerosis. Purinergic Signal. 2025;21:1229\u201331.","journal-title":"Purinergic Signal"},{"key":"8575_CR65","doi-asserted-by":"publisher","first-page":"13423","DOI":"10.2147\/JIR.S549102","volume":"18","author":"M Wang","year":"2025","unstructured":"Wang M, Zhao X, Hou S, Wu Z, Yin HY. Purinergic Receptors in Dendritic Cells. J Inflamm Res. 2025;18:13423\u201332.","journal-title":"J Inflamm Res"},{"key":"8575_CR66","doi-asserted-by":"publisher","first-page":"e0341334","DOI":"10.1371\/journal.pone.0341334","volume":"21","author":"AA Ryback","year":"2026","unstructured":"Ryback AA, Hillier CB, Loureiro CM, Ponting CP, Dalton CF. Indistinguishable mitochondrial phenotypes after exposure of healthy myoblasts to myalgic encephalomyelitis\/chronic fatigue syndrome or control serum. PLoS ONE. 2026;21:e0341334.","journal-title":"PLoS ONE"},{"key":"8575_CR67","doi-asserted-by":"publisher","first-page":"268ra179","DOI":"10.1126\/scitranslmed.3009892","volume":"6","author":"JB Mannick","year":"2014","unstructured":"Mannick JB, Del Giudice G, Lattanzi M, Valiante NM, Praestgaard J, Huang B, Lonetto MA, Maecker HT, Kovarik J, Carson S, et al. mTOR inhibition improves immune function in the elderly. Sci Transl Med. 2014;6:268ra179.","journal-title":"Sci Transl Med"},{"key":"8575_CR68","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s43587-023-00416-y","volume":"3","author":"JB Mannick","year":"2023","unstructured":"Mannick JB, Lamming DW. Targeting the biology of aging with mTOR inhibitors. Nat Aging. 2023;3:642\u201360.","journal-title":"Nat Aging"},{"key":"8575_CR69","doi-asserted-by":"crossref","unstructured":"Cayo A, Segovia R, Venturini W, Moore-Carrasco R, Valenzuela C, Brown N. mTOR activity and autophagy in senescent cells, a complex partnership. Int J Mol Sci. 2021;22.","DOI":"10.3390\/ijms22158149"},{"key":"8575_CR70","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2165\/00003495-200767030-00004","volume":"67","author":"JJ Augustine","year":"2007","unstructured":"Augustine JJ, Bodziak KA, Hricik DE. Use of sirolimus in solid organ transplantation. Drugs. 2007;67:369\u201391.","journal-title":"Drugs"},{"key":"8575_CR71","doi-asserted-by":"publisher","first-page":"44876","DOI":"10.18632\/oncotarget.10381","volume":"7","author":"SC Johnson","year":"2016","unstructured":"Johnson SC, Kaeberlein M. Rapamycin in aging and disease: maximizing efficacy while minimizing side effects. Oncotarget. 2016;7:44876\u20138.","journal-title":"Oncotarget"},{"key":"8575_CR72","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/00007691-200002000-00006","volume":"22","author":"HL Gallant-Haidner","year":"2000","unstructured":"Gallant-Haidner HL, Trepanier DJ, Freitag DG, Yatscoff RW. Pharmacokinetics and metabolism of sirolimus. Ther Drug Monit. 2000;22:31\u20135.","journal-title":"Ther Drug Monit"},{"key":"8575_CR73","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/jcpt.13753","volume":"47","author":"JM Hartinger","year":"2022","unstructured":"Hartinger JM, Rysanek P, Slanar O, Sima M. Pharmacokinetic principles of dose adjustment of mTOR inhibitors in solid organ transplanted patients. J Clin Pharm Ther. 2022;47:1362\u20137.","journal-title":"J Clin Pharm Ther"},{"key":"8575_CR74","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0009-9120(98)00048-4","volume":"31","author":"DJ Trepanier","year":"1998","unstructured":"Trepanier DJ, Gallant H, Legatt DF, Yatscoff RW. Rapamycin: distribution, pharmacokinetics and therapeutic range investigations: an update. Clin Biochem. 1998;31:345\u201351.","journal-title":"Clin Biochem"},{"key":"8575_CR75","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1172\/JCI64099","volume":"123","author":"DW Lamming","year":"2013","unstructured":"Lamming DW, Ye L, Sabatini DM, Baur JA. Rapalogs and mTOR inhibitors as anti-aging therapeutics. J Clin Invest. 2013;123:980\u20139.","journal-title":"J Clin Invest"},{"key":"8575_CR76","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/j.1365-2125.2005.02473.x","volume":"60","author":"C Dansirikul","year":"2005","unstructured":"Dansirikul C, Duffull SB, Morris RG, Tett SE. Relationships between sirolimus dosing, concentration and outcomes in renal transplant recipients. Br J Clin Pharmacol. 2005;60:560\u20135.","journal-title":"Br J Clin Pharmacol"},{"key":"8575_CR77","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1177\/009127009903901107","volume":"39","author":"JJ Zimmerman","year":"1999","unstructured":"Zimmerman JJ, Ferron GM, Lim HK, Parker V. The effect of a high-fat meal on the oral bioavailability of the immunosuppressant sirolimus (rapamycin). J Clin Pharmacol. 1999;39:1155\u201361.","journal-title":"J Clin Pharmacol"},{"key":"8575_CR78","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1249\/MSS.0000000000000990","volume":"48","author":"BD Loy","year":"2016","unstructured":"Loy BD, O\u2019Connor PJ, Dishman RK. Effect of Acute Exercise on Fatigue in People with ME\/CFS\/SEID: A Meta-analysis. Med Sci Sports Exerc. 2016;48:2003\u201312.","journal-title":"Med Sci Sports Exerc"},{"key":"8575_CR79","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1158\/0008-5472.CAN-18-0717","volume":"79","author":"BL Allen-Petersen","year":"2019","unstructured":"Allen-Petersen BL, Risom T, Feng Z, Wang Z, Jenny ZP, Thoma MC, Pelz KR, Morton JP, Sansom OJ, Lopez CD, et al. Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal Adenocarcinoma. Cancer Res. 2019;79:209\u201319.","journal-title":"Cancer Res"},{"key":"8575_CR80","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/s42003-022-03653-w","volume":"5","author":"Y Wang","year":"2022","unstructured":"Wang Y, Li Q, Zhang Z, Peng K, Zhang DM, Yang Q, Passerini AG, Simon SI, Sun C. mTOR contributes to endothelium-dependent vasorelaxation by promoting eNOS expression and preventing eNOS uncoupling. Commun Biol. 2022;5:726.","journal-title":"Commun Biol"},{"key":"8575_CR81","doi-asserted-by":"crossref","unstructured":"Gottschalk CG, Whelan R, Peterson D, Roy A. Detection of elevated level of tetrahydrobiopterin in serum samples of ME\/CFS patients with orthostatic intolerance: a pilot study. Int J Mol Sci. 2023;24.","DOI":"10.3390\/ijms24108713"},{"key":"8575_CR82","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11010-005-2539-9","volume":"269","author":"H Sun","year":"2005","unstructured":"Sun H, Li N, Wang X, Chen T, Shi L, Zhang L, Wang J, Wan T, Cao X. Molecular cloning and characterization of a novel muscle adenylosuccinate synthetase, AdSSL1, from human bone marrow stromal cells. Mol Cell Biochem. 2005;269:85\u201394.","journal-title":"Mol Cell Biochem"},{"key":"8575_CR83","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/B978-0-12-152822-5.50008-7","volume":"22","author":"MM Stayton","year":"1983","unstructured":"Stayton MM, Rudolph FB, Fromm HJ. Regulation, genetics, and properties of adenylosuccinate synthetase: a review. Curr Top Cell Regul. 1983;22:103\u201341.","journal-title":"Curr Top Cell Regul"},{"key":"8575_CR84","doi-asserted-by":"crossref","unstructured":"Rybalka E, Park HJ, Nalini A, Baskar D, Polavarapu K, Durmus H, Xia Y, Wan L, Shieh PB, Moghadaszadeh B, et al. Current insights in ultra-rare adenylosuccinate synthetase 1 myopathy: meeting report on the First Clinical and Scientific Conference, 3 June 2024, National Centre for Advancing Translational Science, Rockville, Maryland, United States of America. Orphanet J Rare Dis. 2024;19:438.","DOI":"10.1186\/s13023-024-03429-x"},{"key":"8575_CR85","doi-asserted-by":"publisher","first-page":"102171","DOI":"10.1016\/j.ceca.2020.102171","volume":"87","author":"Q Zeng","year":"2020","unstructured":"Zeng Q, Zhou Z, Qin S, Yao Y, Qin J, Zhang H, Zhang R, Xu C, Zhang S, Huang S, Chen L. Rapamycin inhibits B-cell activating factor (BAFF)-stimulated cell proliferation and survival by suppressing Ca(2+)-CaMKII-dependent PTEN\/Akt-Erk1\/2 signaling pathway in normal and neoplastic B-lymphoid cells. Cell Calcium. 2020;87:102171.","journal-title":"Cell Calcium"},{"key":"8575_CR86","doi-asserted-by":"publisher","first-page":"104378","DOI":"10.1016\/j.cellimm.2021.104378","volume":"365","author":"X Chen","year":"2021","unstructured":"Chen X, Li S, Long D, Shan J, Li Y. Rapamycin facilitates differentiation of regulatory T cells via enhancement of oxidative phosphorylation. Cell Immunol. 2021;365:104378.","journal-title":"Cell Immunol"},{"key":"8575_CR87","doi-asserted-by":"publisher","first-page":"523","DOI":"10.4161\/auto.6.4.11811","volume":"6","author":"S Amarnath","year":"2010","unstructured":"Amarnath S, Flomerfelt FA, Costanzo CM, Foley JE, Mariotti J, Konecki DM, Gangopadhyay A, Eckhaus M, Wong S, Levine BL, et al. Rapamycin generates anti-apoptotic human Th1\/Tc1 cells via autophagy for induction of xenogeneic GVHD. Autophagy. 2010;6:523\u201341.","journal-title":"Autophagy"},{"key":"8575_CR88","doi-asserted-by":"publisher","first-page":"e36589","DOI":"10.1371\/journal.pone.0036589","volume":"7","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Wu X, Duan J, Hinrichs D, Wegmann K, Zhang GL, Hall M, Rosenbaum JT. Low dose rapamycin exacerbates autoimmune experimental uveitis. PLoS ONE. 2012;7:e36589.","journal-title":"PLoS ONE"},{"key":"8575_CR89","doi-asserted-by":"publisher","first-page":"5970","DOI":"10.1158\/0008-5472.CAN-16-0091","volume":"76","author":"V Dao","year":"2016","unstructured":"Dao V, Liu Y, Pandeswara S, Svatek RS, Gelfond JA, Liu A, Hurez V, Curiel TJ. Immune-Stimulatory Effects of Rapamycin Are Mediated by Stimulation of Antitumor \u03b3\u03b4 T Cells. Cancer Res. 2016;76:5970\u201382.","journal-title":"Cancer Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08575-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08575-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08575-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T07:03:58Z","timestamp":1784185438000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08575-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8575"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08575-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"15 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted under a central protocol (SRI-RP-2023-1) and all sites were approved by the Western Institutional Review Board (WIRB Study Number: 1361805). The study complies with the standard ethical principles developed and maintained by World Medical Association (WMA) under the declaration of Helsinki. The IBC protocol (Protocol # B26.015) for conducting basic research on PBMCs has been approved by University of Wisconsin-Milwaukee. Simmaron Research Inc. is the study sponsor, and the trial was registered on ClinicalTrials.gov (NCT06257420). No part of this research article, including images and texts, has been published or reproduced in any book, article, or other published literature. The images were original and not copied from any other source.","order":1,"name":"Ethics","label":"Ethics and institutional review board","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants consented to the study.","order":2,"name":"Ethics","label":"Consent to participate in the trial","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors provided consent to publish this original research article.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"921"}}